{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
deucravacitinib
to a specific field?
There is one exact (name or code) match for deucravacitinib
Status:
US Approved Rx
(2022)
Source:
NDA214958
(2022)
Source URL:
First approved in 2022
Source:
NDA214958
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Showing 1 - 8 of 8 results
Status:
US Approved Rx
(2022)
Source:
NDA214958
(2022)
Source URL:
First approved in 2022
Source:
NDA214958
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
Possibly Marketed Outside US
Source:
Octaplasma by Octapharma Pharmazeutika Produktionsges M B H [Canada]
Source URL:
First approved in 2013
Source:
BLA125416
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT00004070: Phase 1/Phase 2 Interventional Completed Head and Neck Cancer
(1999)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
US Approved Rx
(2022)
Source:
NDA214958
(2022)
Source URL:
First approved in 2022
Source:
NDA214958
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
